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Abstract
Laparoscopic sleeve gastrectomy (LSG) has reached 
wide popularity during the last 15 years, due to the 
limited morbidity and mortality rates, and the very 
good weight loss results and effects on comorbid 
conditions. However, there are concerns regarding 
the effects of LSG on gastroesophageal reflux disease 
(GERD). The interpretation of the current evidence 
is challenged by the fact that the LSG technique is 
not standardized, and most studies investigate the 
presence of GERD by assessing symptoms and the 
use of acid reducing medications only. A few studies 
objectively investigated gastroesophageal function and 
the reflux profile by esophageal manometry and 24-h 
pH monitoring, reporting postoperative normalization 
of esophageal acid exposure in up to 85% of patients 
with preoperative GERD, and occurrence of de novo 
GERD in about 5% of cases. There is increasing evi-
dence showing the key role of the surgical technique 
on the incidence of postoperative GERD. Main technical 
issues are a relative narrowing of the mid portion 
of the gastric sleeve, a redundant upper part of the 
sleeve (both depending on the angle under which the 
sleeve is stapled), and the presence of a hiatal hernia. 
Concomitant hiatal hernia repair is recommended. 
To date, either medical therapy with proton pump 
inhibitors or conversion of LSG to laparoscopic Roux-
en-Y gastric bypass are the available options for the 
management of GERD after LSG. Recently, new mini-
mally invasive approaches have been proposed in 
patients with GERD and hypotensive LES: the LINX® 
Reflux Management System procedure and the Stre-
tta® procedure. Large studies are needed to assess the 
safety and long-term efficacy of these new approaches. 
In conclusion, the recent publication of pH monitoring 
data and the new insights in the association between 
sleeve morphology and GERD control have led to a 
wider acceptance of LSG as bariatric procedure also 
in obese patients with GERD, as recently stated in 
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Core tip: The current evidence about reflux control and 
the occurrence of de novo gastroesophageal reflux 
disease (GERD) after laparoscopic sleeve gastrectomy 
(LSG) is controversial. Recent studies that have 
objectively evaluated GERD after LSG have shown no 
significant increase in postoperative GERD. The absence 
of mid-stomach narrowing and retained fundus, and 
the repair of a concomitant hiatal hernia seem to 
be key in reducing the risk of postoperative GERD. 
We discuss the currently available evidence on the 
impact of LSG on GERD, focusing on surgical technical 
aspects and new minimally invasive approaches for the 
management of postoperative GERD.
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INTRODUCTION
Gastroesophageal reflux disease (GERD) is a highly 
prevalent condition in morbid obese patients[1]. The 
pathophysiology by which the increase in body mass 
index leads to increase in esophageal acid exposure 
is multifactorial, with the increased intraabdominal 
pressure playing a major role[2]. Laparoscopic Roux-
en-Y gastric bypass (LRYGB) is considered by most 
experts the procedure of choice for the management 
of GERD in obese patients, with excellent results in 
terms of reflux control and long lasting weight loss[3,4]. 
During the last 15 years, laparoscopic sleeve gas-
trectomy (LSG) has rapidly become a very popular 
bariatric procedure, since it is less technically de-
manding than LRYGB, it is burdened by low rates of 
postoperative complications, and it is associated with 
significant weight loss and improvement or resolution 
of several comorbidities[5]. However, the effect of LSG 
on GERD is still unclear, with conflicting evidence about 
pre-existing reflux control and the occurrence of de 
novo GERD after surgery[6]. 
The aim of this paper is to critically analyze the 
impact of LSG on GERD, in terms of symptom control 
and changes in gastro-esophageal function. Surgical 
technical aspects, including the shape of the sleeve 
and the repair of a concomitant hiatal hernia, and new 
minimally invasive approaches to manage postoperative 
GERD are also discussed.
GERD AND LSG: THE EVIDENCE
Several studies have evaluated the effects of LSG 
on pre-existing GERD and on the new onset of 
GERD, showing controversial results: some reported 
amelioration of GERD, while others showed the posto-
perative occurrence of de novo GERD or worsening of 
preoperative GERD[7-44] (Table 1). The analysis of the 
literature is challenged by the heterogeneity of the 
studies in regard to the definition of GERD the timing 
of patients’ evaluation. Most studies defined GERD 
based on proton pump inhibitors (PPIs) use, symptoms 
evaluation, and presence of esophagitis.  Only few 
studies objectively analyzed patients by esophageal 
manometry and 24-pH monitoring[15,20,29,33,34,38,40,43,44].
Discordant data are available regarding the change 
in the use of PPIs. While Catheline et al[25] observed 
an increase in the use of PPI from 11.1% to 33.3% 
at 5 years after LSG, a large population-based study 
involving 1567 obese patients treated with LSG 
found that 37.3% of patients who used acid reducing 
medications preoperatively discontinued the treatment 
at 1 year[39]. This discordance is secondary to the fact 
that the use of acid reducing medications has a poor 
correlation with the presence of real GERD[19].
The studies that used validated questionnaires 
to assess the prevalence of GERD after LSG report 
conflicting results. For instance, Carter et al[16] found 
that among 176 obese patients treated by LSG, the 
incidence of GERD symptoms increased from 34.6% to 
47.2%. Conversely, DuPree et al[36] found a decrease in 
GERD symptoms prevalence after LSG. They conducted 
a retrospective review of the Bariatric Outcomes 
Longitudinal Database over a 4-year period, including 
a total of 4832 patients who had LSG for morbid 
obesity, reporting resolution of symptoms in 15.9%. 
We recently published the results of a prospective study 
aiming to evaluate the physiopathologic changes after 
LSG[38]. A total of 28 patients with preoperative 24-h pH 
monitoring positive for pathological reflux completed the 
Gastroesophageal reflux disease Symptom Assessment 
Scale (GSAS) questionnaire preoperatively and at 2 
year-follow-up: the decrease in the GSAS score demon-
strated a significant improvement of symptoms.
New-onset GERD has been investigated based 
on symptom evaluation by several studies, reporting 
a wide range of incidence, from 0% to 34.9%. For 
instance, Himpens et al[12] invited 30 obese patients at 
6 years or more after LSG to complete a questionnaire 
on GERD symptoms. They reported new-onset GERD 
symptoms in 23% of patients. However, the absence of 
24-h pH monitoring data challenges the interpretation 
of these findings. In a recently published prospective 
series, we observed that GERD symptoms were present 
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in all obese patients with positive 24-h pH monitoring 
at 2 years after surgery. However, the evaluation of the 
correlation of symptoms with the pH monitoring trace 
showed that only 5.4% (2/37) patients had real “de 
novo” GERD.  Outlet obstruction in the upper portion of 
the gastric sleeve producing symptoms simulating “de 
novo” GERD caused the pH decrease below 4 in 13.5% 
(5/37) patients[38]. These controversial findings highlight 
the fact that GERD cannot be diagnosed on the basis 
of symptoms evaluation only, since the sensitivity and 
specificity of typical symptoms is low and leads to a 
wrong diagnosis of GERD occurs in about one third of 
cases[45]. 
To date, only a few studies have specifically 
looked at changes in esophageal function after LSG 
by using esophageal manometry, 24-h pH monitoring 
or 24-h MII pH monitoring.  Regarding manometric 
changes, very controversial data have been pub-
lished[15,20,29,33,34,38,40]. Some small studies have found a 
significant decrease in lower esophageal sphincter (LES) 
pressure, while others showed a significant increase in 
LES pressure postoperatively. For instance, Braghetto 
et al[15] prospectively evaluated 20 patients undergoing 
LSG for morbid obesity. They showed that LES pressure 
significantly decreased in 85% of patients at 6 mo 
after surgery. Total length and abdominal length of the 
high pressure zone were also reduced. The authors 
proposed the partial section of the sling fibers of the 
cardias as cause of these findings. On the contrary, 
Petersen et al[20] reported an increase in LES pressure 
regardless of the weight loss, suggesting that this 
manometric change is related to the position of the 
stapler in relation to the angle of His. Specifically, the 
closer the staple line to the gastroesophageal junction, 
the higher the LES pressure.  In our prospective study 
of 65 patients, we observed no significant manometric 
changes in LES pressure and esophageal peristalsis 
amplitude[38]. Only Del Genio et al[33] showed in a series 
of 25 obese patients an increase in ineffective peristalsis 
with no changes in LES function at a median follow-up 
of 13 mo.
Only 4 studies[33,38,40,43] have objectively evaluated 
the presence of pathologic reflux by 24-h MII pH 
monitoring or 24-h pH monitoring at 12 mo or more 
after LSG, reporting conflicting results. Del Genio et al[33] 
reported the results in a series of 25 obese patients 
with no preoperative GERD, who were evaluated with 
24-h MII pH monitoring preoperatively and 13 mo 
postoperatively. They detected a significant increase in 
the median DeMeester’s score (DMS), in the median 
percentage with esophageal pH < 4 in supine position, 
the total number of reflux episodes non-acid reflux 
episodes in both upright and recumbent position. 
Gorodner et al[40] prospectively assessed the esophageal 
function in 14 obese patients preoperatively and at 
1 year after LSG. The DMS increased from 12.6 to 
28.4 (p < 0.05): in particular, the number of episodes 
longer than 5 min, duration of longest episode, % of 
time the pH < 4 (total) increased. Overall, “de novo” 
GERD developed in 5 (36%) patients, while pre-existing 
GERD got worse in 3 (21%) patients. Very recently, 
Georgia et al[43] prospectively studied 12 obese patients 
without preoperative reflux symptoms by using 24-h 
multichannel intraluminal impedance-pHmetry (MIIpH) 
before and one year after LSG. Mean preoperative DMS 
was 18.15. DMS was abnormal in 5 (42.7%) patients. 
Postoperatively, abnormal DMS was detected in 10 
(83.3%) patients. At one year after surgery, DMS was 
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Table 1  Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: Evidence from studies with more than 45 patients 
followed up for at least 12 mo after surgery
Ref. No. of 
patients
Follow-up 
(mo)
GERD 
symptoms
Use of acid 
reducing 
medications
LES 
pressure
Peristalsis 
amplitude
DMS New onset GERD 
symptoms (%)
New onset pathologic 
esophageal acid 
exposure (%)
Moon Han et al[7]   60 12 ↓ NR NR NR NR   0 NR
Weiner et al[9] 120 24 ↓ ↓ NR NR NR NR NR
Arias et al[11] 130 24 ↑ NR NR NR NR      2.1 NR
Lakdawala et al[14]   50 12 ↑ NR NR NR NR   4 NR
Carter et al[16] 176 12 ↑ ↑ NR NR NR    12.6 NR
Mohos et al[18]   47 38 ↔ ↔ NR NR NR NR NR
Chopra et al[21] 185 16 ↓ NR NR NR NR      3.7 NR
Abrahim et al[23]   83 12 ↑ NR NR NR NR    11.4 NR
Tai et al[24]   66 12 ↑ NR NR NR NR    44.8 NR
Catheline et al[25]   45 60 ↑ ↑ NR NR NR    22.2 NR
Rawlins et al[26]   49 60 ↓ NR NR NR NR 11 NR
Zhang et al[28] 200 12 ↔ ↔ NR NR NR      0.2 NR
Carabotti et al[30]   74 13 ↔ NR NR NR NR 22 NR
Sharma et al[32]   32 12 ↓ NR NR NR NR NR NR
Kular et al[35]   76 60 ↑ NR NR NR NR    15.7 NR
Våge et al[37] 117 24 ↑ NR NR NR NR    14.6 NR
Rebecchi et al[38]   65 24 ↓ ↓ ↔ ↔ ↓      5.4 5.4
Sheppard et al[42] 205 12 ↑ ↑ NR NR NR NR NR
GERD: Gastroesophageal reflux disease; LES: Lower esophageal sphincter; DMS: DeMeester score; ↑: Increase; ↔:  No differences; ↓: Decrease; NR: Not 
reported.
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narrowing impairs the emptying of the upper part of the 
sleeve, causes food stasis and fermentation, while the 
retained fundus keeps producing acid, thus favouring 
the onset of reflux of acid gastric contents into the 
esophagus. Similar findings were recently reported 
by Toro et al[49]. They reviewed 76 patients who had 
routine upper gastrointestinal series with Gastrografin 
on postoperative day 1 or 2 after LSG and completed 
the GERD-HRQL score. Sleeve shape was classified as 
upper pouch, lower pouch, tubular or dumbbell. At 12 
mo, 59.2% of patients did not report any GERD-related 
symptom, while only 7.8% complained moderate to 
severe reflux symptoms. Patients with the upper pouch 
shape had the highest severity of symptoms according 
to the GERD-HRQL score. The lower pouch shape was 
on the contrary associated with fewer GERD symptoms, 
suggesting an effective gastric emptying when the 
antrum is preserved.
The impact of the size of the bougie on the pre-
vention of sleeve narrowing and GERD is unclear, since 
there is no standardization of the surgical technique (the 
diameter of the bougies used ranges between 26.4 Fr to 
50 Fr). While there is increasing consensus that smaller 
bougies are associated with leaks secondary to gastric 
strictures[50], the limited data available do not allow to 
draw any association between the size of the bougie 
and GERD. The use of a smaller bougie might lead to 
the creation of a narrower sleeve with a higher intra-
sleeve pressure, thus exposing the patient to a higher 
risk of postoperative GERD. However, the use of a 
larger bougie might also favour the occurrence of GERD 
because the creation of a larger sleeve is associated 
with reduced weight loss and increased number of 
residual parietal cells.
Finally, the presence of a hiatal hernia is not con-
sidered by many bariatric surgeons a contraindication 
to LSG[50]. However, the current evidence on this topic is 
limited by several factors: (1) there are very few studies 
including more than 100 patients; (2) mean follow-up 
is short; and (3) those studies that describe the hiatal 
hernia repair report different ways to close the hiatus: 
suture posterior cruroplasty (most common), suture 
anterior cruroplasty. and hiatal herniorrhaphy with 
mesh (biological or polypropylene mesh). In addition, 
all studies based their results on symptom evalua-
tion without assessing postoperative GERD by 24-h 
pH monitoring or 24-h pH MII monitoring. A recent 
review of the literature[51] investigated the results and 
the technical aspects of simultaneous LSG and hiatal 
hernia repair. A total of 17 studies (737 patients) were 
included. Mean follow-up was 13.9 mo. Most studies 
reported satisfactory postoperative results in terms 
of reduction of symptoms and use of acid reducing 
medications[52]. However, less satisfactory results have 
been recently reported[53,54]. For instance, Santonicola 
et al[53] compared 78 patients undergoing LSG and HH 
repair with 102 patients without HH who underwent 
LSG alone. With a mean follow-up of 14.6 mo in the 
almost 2.5 times higher than the preoperative DMS.
In our study[38], 24-h pH monitoring performed at 
2 years after surgery in 28 patients with preoperative 
GERD showed significantly decreased DMS and total 
%pH < 4. Four (14.3%) patients still had pathologic, 
even though reduced, esophageal acid exposure. 
We observed a significant postoperative decrease in 
both mean symptom index (SI) score and percentage 
of patients with SI greater than 50% (from 89.3% 
preoperatively to 14.3% postoperatively). Among 
patients with negative preoperative 24-h pH monitoring, 
7 (18.9%) patients had pathologic DMS and total 
%pH < 4. No significant changes in the mean SI score 
were reported at 2 years after LSG compared with the 
baseline value. Overall, we observed a slightly increase 
in the percentage of patients with SI of more than 
50%, from 8.1% before LSG to 18.9% at 2 years after 
LSG (p = 0.308).  However, as mentioned before, real 
“de novo” GERD was detected in 5.4% (2/37) patients 
according to the correlation between symptoms and the 
24-h pH monitoring data. 
PROPOSED MECHANISMS FAVORING 
THE OCCURRENCE OF GERD AFTER LSG
Several anatomic and pathophysiologic changes of the 
LES function secondary to the creation of the gastric 
sleeve that might cause GERD after LSG have been 
hypothesized. While data regarding LES function are 
scarce and controversial, there is increasing evidence 
supporting the key role of the surgical technique on 
the incidence of postoperative GERD. Main surgical 
technical issues are: a relative narrowing of the mid 
portion of the sleeve, a redundant upper part of 
the sleeve and the presence of a concomitant hiatal 
hernia[46].
The shape of the gastric sleeve plays a major role 
in leading to GERD. For instance, Himpens et al[47] 
noted that GERD symptoms were reported by 21.8% 
of patients at 1 year after LSG, by 3.1% of patients at 
3 years and again by 23% of patients at 6-year follow-
up[12]. While the decrease of the incidence of GERD 
symptoms may be secondary to the increase in gastric 
compliance, the late reappearance of symptoms might 
be explained by weight regain with associated increased 
intra-abdominal pressure, and dilatation of the proximal 
sleeve leading to the formation of a “neofundus”[12]. 
Keidar et al[48] reviewed the UGI Gastrografin series 
obtained on postoperative day 1 in 8 patients who 
developed postoperative GERD. They found that a 
combination of dilated upper portion of the sleeve and 
a relative narrowing of the mid-stomach was present in 
all patients. This anatomical situation may be secondary 
to a too narrow construction of the sleeve in association 
with retention of part of the gastric fundus by stapling 
far away from the left pillar of the crus, in order to 
minimize the risk of postoperative upper gastric fistulas. 
It has been speculated that the relative mid-gastric 
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LSG with HH repair group and 17.1 mo in the LSG 
only group, a significant reduction in the prevalence of 
GERD symptoms was reported only in patients treated 
with LSG alone, while no improvement was observed 
among patients undergoing LSG and HH repair.  In the 
absence of recommendations about the use of mesh 
to close large hiatal hernia defects, Ruscio et al[55] 
recently reported no mortality and no mesh-related 
complications in 48 patients undergoing LSG with on-
lay synthetic absorbable mesh-reinforced cruroplasty for 
a large HH (hiatal area defect > 4 and < 8 cm2). With 
a mean follow-up of 19 mo, GERD symptoms  resolved 
in 95% of patients, while de novo GERD symptoms 
developed in 3.6% of patients: 
We feel that large prospective (randomized) studies 
with long follow-up and objective evaluation of GERD 
are needed before drawing any definitive conclusion 
on the real effect of LSG in patients with concomitant 
hiatal hernia.
TREATMENT OPTIONS OF GERD IN 
PATIENTS AFTER LSG: THE PRESENT 
AND FUTURE PERSPECTIVES 
Medical therapy with PPIs represents the initial 
treatment option in patients with GERD after LSG. 
However, data reported in the literature regarding the 
efficacy of this approach are heterogeneous, mainly 
due to the lack of consistency in defining GERD. For 
instance, Hendricks et al[56] recently analyzed 919 
obese patients undergoing LSG. GERD was defined 
based on pH manometric findings. They found de 
novo GERD in 3% of patients: most patients were 
successfully managed with low or high doses of PPIs 
and conversion to LRYGB was necessary in only 4% of 
them. Sheppard et al[42] found similar results. On the 
contrary, other authors reported high rates of failure of 
PPI therapy, suggesting revisional surgery in patients 
with refractory GERD after LSG[57,58]. 
To date, conversion of LSG to LRYGB is the pro-
cedure of choice in patients with objectively docu-
mented postoperative GERD. Several studies have 
reported excellent results in terms of improvement 
or resolution of reflux symptoms[57-61]. Revisional 
minimally invasive gastric gastric bypass is highly 
effective in controlling GERD related symptoms and 
is currently the standard option in these patients[62]. 
Very recently, new minimally invasive approaches 
have been proposed in patients with GERD and 
hypotensive LES: the LINX® Reflux Management 
System procedure and the Stretta® procedure. Desart 
et al[63] retrospectively revised retrospective reviewed 
7 consecutive patients treated with the laparoscopic 
placement of the LINX® magnetic sphincter device 
(Torax Medical Inc, Shoreview, MN, United States) 
for refractory GERD after LSG. All patients reported a 
significant improvement in GERS symptoms at 2 to 4 
wk after surgery. While these results are promising, 
the few patients evaluated and the lack of long-term 
follow-up do not let draw any conclusion and further 
large prospective studies are awaited.
The Stretta® (Mederi Therapeutics Inc, Norwalk, 
CT, United States) procedure has been studied in non-
obese patients only, and has been shown to lead to 
durable improvement of symptoms and decrease in 
acid reducing medications use in selected patients[64,65]. 
The first study that will give some information about 
the outcomes in patients treated with Stretta after 
LSG is the ongoing observational prospective study 
Management of Reflux after Sleeve using Stretta 
(MaRSS), ClinicalTrials.gov Identifier: NCT02637713.
CONCLUSION
There is a multifactorial relationship between LSG and 
GERD. Most recent studies have shown satisfactory 
postoperative reflux control in the majority of patients 
and low rates of de novo GERD. The shape of the 
gastric sleeve appears to be one of the main factors 
predicting the risk of postoperative GERD. These data 
are leading to a wider acceptance of LSG as bariatric 
procedure also in obese patients with GERD, provided 
that a tubular sleeve is created, as recently stated in 
the 5th International Consensus Conference on sleeve 
gastrectomy[50]. 
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